IRIS UniCatt

Pandolfi, Franco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.780
AS - Asia 3.722
EU - Europa 3.260
SA - Sud America 729
AF - Africa 75
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 3
Totale 12.589
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.673
SG - Singapore 1.815
CN - Cina 924
DE - Germania 883
BR - Brasile 616
SE - Svezia 531
UA - Ucraina 516
FR - Francia 324
IT - Italia 272
VN - Vietnam 246
IE - Irlanda 222
FI - Finlandia 136
ID - Indonesia 135
GB - Regno Unito 128
IN - India 123
RU - Federazione Russa 95
JP - Giappone 83
BD - Bangladesh 79
HK - Hong Kong 56
TR - Turchia 52
AR - Argentina 41
IQ - Iraq 39
CA - Canada 38
MX - Messico 38
PL - Polonia 30
NL - Olanda 25
ZA - Sudafrica 25
PK - Pakistan 23
SA - Arabia Saudita 23
BE - Belgio 22
AU - Australia 18
CO - Colombia 15
ES - Italia 13
VE - Venezuela 13
KR - Corea 12
CL - Cile 11
UZ - Uzbekistan 11
EC - Ecuador 10
IR - Iran 10
JM - Giamaica 10
MA - Marocco 10
PH - Filippine 10
CH - Svizzera 9
AZ - Azerbaigian 8
PY - Paraguay 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
IL - Israele 7
JO - Giordania 7
KE - Kenya 7
UY - Uruguay 7
DZ - Algeria 6
KZ - Kazakistan 6
NP - Nepal 6
CZ - Repubblica Ceca 5
LB - Libano 5
MY - Malesia 5
PE - Perù 5
AL - Albania 4
AT - Austria 4
DK - Danimarca 4
EG - Egitto 4
LT - Lituania 4
MK - Macedonia 4
PA - Panama 4
PT - Portogallo 4
RO - Romania 4
BH - Bahrain 3
BO - Bolivia 3
CI - Costa d'Avorio 3
ET - Etiopia 3
HU - Ungheria 3
KG - Kirghizistan 3
MM - Myanmar 3
MN - Mongolia 3
OM - Oman 3
PS - Palestinian Territory 3
RS - Serbia 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BY - Bielorussia 2
BZ - Belize 2
CR - Costa Rica 2
GT - Guatemala 2
HN - Honduras 2
IS - Islanda 2
KW - Kuwait 2
NI - Nicaragua 2
NO - Norvegia 2
QA - Qatar 2
RE - Reunion 2
SN - Senegal 2
SV - El Salvador 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BM - Bermuda 1
BN - Brunei Darussalam 1
Totale 12.572
Salva come PNG Salva come JPEG
Città #
Singapore 881
Ashburn 640
Chandler 515
San Jose 509
Jacksonville 264
Dublin 214
San Mateo 214
Beijing 195
Wilmington 125
Jakarta 124
Nanjing 111
Ann Arbor 108
Lauterbourg 105
Boston 89
Hefei 89
Lawrence 89
Hanoi 74
Los Angeles 74
Cattolica 73
Dearborn 69
New York 66
Ho Chi Minh City 65
Moscow 63
Tokyo 63
Houston 62
Woodbridge 52
Boardman 47
Fairfield 47
Redwood City 47
Hong Kong 45
Seattle 44
Frankfurt am Main 43
São Paulo 42
Dallas 41
Buffalo 38
Detroit 37
Marseille 34
Milan 34
Mountain View 34
Helsinki 33
Kent 33
Nürnberg 33
Hangzhou 32
Lancaster 32
Nanchang 32
Santa Clara 32
Shenyang 32
Chicago 31
Munich 31
University Park 31
Rio de Janeiro 30
Hebei 29
Shanghai 29
Princeton 23
Izmir 22
Rome 22
Brussels 20
Bremen 19
Cambridge 19
Guangzhou 19
Norwalk 19
Changsha 18
Jiaxing 18
Baghdad 17
Brooklyn 16
The Dalles 16
Washington 16
Da Nang 15
Paris 15
Tianjin 15
Jinan 14
Kraków 14
London 14
Zhengzhou 14
Atlanta 13
Belo Horizonte 13
Council Bluffs 13
Pune 13
Fremont 12
Johannesburg 12
Tukwila 12
Ankara 11
Nuremberg 11
Brasília 10
Dhaka 10
Düsseldorf 10
Philadelphia 10
Simi Valley 10
Tashkent 10
Toronto 10
Warsaw 10
Curitiba 9
Denver 9
Jeddah 9
Kingston 9
Kunming 9
Lahore 9
Leawood 9
Memphis 9
Porto Alegre 9
Totale 6.542
Salva come PNG Salva come JPEG
Nome #
Impact of mast cells in rejection of allografts 185
Can vitamin a mediate immunity and inflammation? 181
Skewed T-cell receptor repertoire: more than a marker of malignancy, a tool to dissect the immunopathology of inflammatory diseases 176
Skewed T-cell receptor repertoire: more than a marker of malignancy, a tool to dissect the immunopathology of inflammatory diseases 168
Relationship between gastric localization of hepatitis C virus and mucosa-associated lymphoid tissue in Helicobacter pylori infection 164
The role of IL-15 in gastrointestinal diseases: a bridge between innate and adaptive immune response 160
Key Role of DAMP in Inflammation, Cancer, and Tissue Repair 157
Tissue-infiltrating lymphocytes analysis reveals large modifications of the duodenal "immunological niche" in coeliac disease after gluten-free diet. 157
Uncomplicated Diverticular Disease: Innate and Adaptive Immunity in Human Gut Mucosa before and after Rifaximin 157
Interleukin-6 in Rheumatoid Arthritis 156
Comment on: Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system. 151
How the Intricate Interaction among Toll-Like Receptors, Microbiota, and Intestinal Immunity Can Influence Gastrointestinal Pathology 151
Reflux symptoms in wind instrument players. 146
The immune response to tumors as a tool toward immunotherapy 145
Role of vitamins D, E and C in immunity and inflammation. 144
IL-32: a newly-discovered proinflammatory cytokine 141
Recent insights in primary immunodeficiency diseases: the role of T-lymphocytes and innate immunity. 141
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 140
The involvement of IgH enhancer HS1.2 in the pathogenesis of Crohn's disease: how the immune system can influence a multifactorial disease 139
Third-line rescue therapy for Helicobacter pylori infection 138
The importance of complying with vaccination protocols in developed countries: "anti-vax" hysteria and the spread of severe preventable diseases 138
Common variable immunodeficiency - new insight into the pathogenesis and the quest for a workable classification. 137
New insights on the role of T-cels in the pathogenesis of Celiac Disease 136
Central and Mucosal Immunities are Modified by Non Adsorbable Antibiotic Treatment in Uncomplicated Diverticular Disease 136
New insights on the role of T cells in the pathogenesis of celiac disease. 134
Comment on: Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system 131
Nickel allergy in lipid transfer protein sensitized patients: Prevalence and clinical features 131
The Interaction among Microbiota, Immunity, and Genetic and Dietary Factors Is the Condicio Sine Qua Non Celiac Disease Can Develop 130
Allele *1 of HS1.2 enhancer associates with selective IgA deficiency and IgM concentration 129
Allele*1 of HS1,2 enhancer associates with selective IgA deficiency and IgM concentration 126
Cellular mediators of inflammation: tregs and t(h)17 cells in gastrointestinal diseases. 126
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 126
Immune Modulation by Vitamin D: Special Emphasis on Its Role in Prevention and Treatment of Cancer. 125
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 124
Interrelationship between IL-3 and mast cells 123
T-cell receptor repertoire and function in patients with Di George Syndrome and velocardiofacial syndrome. 123
Third-line rescue therapy for Helicobacter pylori infection. 120
Impact of IL-18 on inflammation 118
TLR2: a crossroads between infections and autoimmunity? 117
Increased osteoclastic activity in acute Charcot's osteoarthopathy: the role of receptor activator of nuclear factor-kappa B ligand 116
Activity of caffeic acid derivatives against Candida albicans biofilm 115
Current Challenges in Immunology 114
Luteolin inhibits mast cell-mediated allergic inflammation. 113
Integrins: Integrating the Biology and Therapy of Cell-cell Interactions 113
Increased frequency of Ig heavy-chain HS1,2-A enhancer *2 allele in dermatitis herpetiformis, plaque psoriasis, and psoriatic arthritis. 112
TLR2: a crossroads between infections and autoimmunity? 112
Tissue infiltrating lymphocytes: the role of cytokines in their growth and differentiation. 111
Luteolin, inflammation and cancer: Special emphasis on gut microbiota 111
Cellular mediators of inflammation: tregs and TH17 cells in gastrointestinal diseases. 110
VEGF, substance P and stress, new aspects: a revisited study. 109
Low-dose IL-2 reduces lymphocyte apoptosis and increases naive CD4 cells in HIV-1 patients treated with HAART 108
Strategies to overcome obstacles to successful immunotherapy of melanoma. 108
Impairment of recent thymic emigrants in HCV infection. 107
Mast cell involvement in rheumatoid arthritis. 106
Impact of Fungi on Immune Responses 106
High prevalence of hyperplastic colonic polyps in acromegalic subjects 105
The impact of biological agents interfering with receptor/ligand binding in the immune system. 105
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 103
Role of mast cells in innate and adaptive immunity. 102
Apoptosis in asymptomatic HIV-1 seropositives immunized with HIV-1 env glycoprotein (gp160): effects of administration of Zidovudine in vivo and IL-2 in vitro 102
BALKAN ENDEMIC NEPHROPATHY RISK ASSOCIATES TO THE HS1.2 IG ENHANCER POLYMORPHISM 101
Mast Cells Mediate Rheumatoid Arthritis-Inhibitory Role of IL-37 99
Neuropeptide NGF mediates neuro-immune response and inflammation through mast cell activation 98
The number of HIV-DNA infected mononuclear cells is reduced under HAART plus recombinant IL-2. 97
Abnormal synthesis of IgA in coeliac disease and related disorderd 97
New insight into systemic mastocytosis mediated by cytokines IL-1 beta and IL-33: Potential inhibitory effect of IL-37 97
Biased T cell receptor repertoires in patients with chromosome 22q11.2 deletion syndrome (Di George syndrome/velocardiofacial syndrome) 96
Structure and expression of the human ubiquitin fusion-degradation gene (UFD1L). 96
The Italian quality control study for evaluation of CD4 cells in centres involved in the treatment of HIV-1 patients. Italian CD4 Quality Control Group 96
Melanoma antigen recognition by tumor-infiltrating T lymphocytes (TIL): effect of differential expression of melan-A/MART-1 96
Apoptosis in the homeostasis of the immune system and in human immune mediated diseases 96
IL-31 a Th2 cytokine involved in immunity and inflammation. 96
Strategies to overcome obstacles to successful immunotherapy of melanoma 94
Involvment of central immunity in uncomplicated diverticular disease. 94
Vascular endothelial growth factor (VEGF), mast cells and inflammation. 93
Changes in host cell molecules acquired by circulating HIV-1 in patients treated with highly active antiretroviral therapy and interleukin-2. 92
Comparison of beneficial actions of non-steroidal anti-inflammatory drugs to flavonoids 92
A novel autocrine pathway of tumor escape immune recognition; melanoma cell produce a soluble protein that diminuishes expression of the gene encoding the melanocyte lineage melan-A/MART-1 antigen through down modulation of its promoter. 91
Heat shock protein-90 inhibitors enhance antigen expression on melanomas and increase T cell recognition of tumor cells 91
Impact of mast cells on the skin. 90
Nerve growth factor interactions with mast cells 89
Increased frequency of the immunoglobulin enhancer HS1,2 allele 2 in coeliac disease 88
Induction of "antigen silencing" in melanomas by oncostatin M: downmodulation of melanocyte antigen expression. 87
Active thymopoiesis in idiopathic chronic pancreatitis 86
Vitamins and mast cells. 85
Oligoclonality of Vdelta1 and Vdelta2 cells in human peripheral blood mononuclear cells: TCR selection is not altered by stimulation with gram-negative bacteria 84
Decreased CD 95 expression on naive T cells from HIV infected persons undergoing highly active antiretroviral therapy (HAART) and the influence of IL-2 low dose administration 83
HIV type 1-induced inhibition of CD45 tyrosine phosphatase activity correlates with disease progression and apoptosis, but not with anti-CD3-induced T cell proliferation 83
Gut microbiota and immunity in common variable immunodeficiency: crosstalk with pro-inflammatory cytokines 83
Studies of the mechanism of cytolysis by tumour-infiltrating lymphocytes 82
Interrelationship between IL-3 and mast cells 82
Epatite da farmaci 81
Impact of IL -9 and IL-33 in mast cells 81
Psychological stress and vitamins 78
Nutrition and cancer prevention 78
Apoptotic effect of cyclosporin a and dexamethasone in malignant cells of patients with B-chronic lymphocytic leukemia. 77
Nerve growth factor interactions with mast cells 77
Impact of capsaicin on mast cell inflammation. 76
IL-36 receptor antagonist with special emphasis on IL-38. 76
Allergic inflammation: role of cytokines with special emphasis on IL-4 76
Totale 11.349
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.644
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.644
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202128 0 0 0 0 0 0 0 0 0 0 0 28
2021/2022881 65 128 15 63 47 34 11 127 39 44 118 190
2022/20231.587 233 182 156 207 156 203 55 94 166 44 60 31
2023/2024918 30 284 25 129 27 107 23 44 21 39 93 96
2024/20251.646 46 72 146 38 107 51 18 112 298 114 325 319
2025/20264.316 702 132 301 411 697 206 732 215 273 349 176 122
Totale 12.678